The combination of advanced glycation end products and corresponding receptors directly or indirectly leads to the occurrence and development of cerebrovascular disease, whereas reduced PPARγ expression can exacerbate this central nervous injury. This evidence concerns the gene PPARG and cerebrovascular disorder.